Abstract
- All those who are unvaccinated or incompletely vaccinated are strongly recommended to complete a primary COVID-19 vaccination course. Seasonal influenza vaccine can be given at the same time, to those for whom it is recommended.
- All must continue to observe all recommended public health and social measures. The use of masks, physical distancing, hand hygiene, and ventilation of indoor spaces are key to reducing transmission of SARS-CoV-2. Booster vaccines will not immediately contribute to outbreak management and do not take the place of public health and social measures.
- In addition to prior recommendations, a booster dose of an mRNA vaccine is recommended in order of priority for
- Healthcare workers, including those pregnant (priority for frontline HCWs)
- Those aged 16-59 years with underlying conditions as listed in Table 5a.2 of Chapter 5a COVID-19 in the Immunisation Guidelines for Ireland and all residents in long term healthcare facilities
- Those aged 50-59 years For those aged 16-29 years, a full dose of Comirnaty (0.3ml/30 micrograms) should be given six months or longer following completion of a primary two dose course of any COVID-19 vaccine. For those aged 30 years and older, a full dose of Comirnaty (0.3ml/30 micrograms) or a half dose of Spikevax (0.25ml/50 micrograms) should be given six months or longer following completion of a primary two dose course of any COVID-19 vaccine. A minimum interval of five months may be used when necessary for operational reasons. Recipients of COVID-19 vaccine Janssen should receive an mRNA booster dose after an interval of three months.
4.Those who have a breakthrough infection following a primary vaccination course should defer booster vaccination for at least six months following infection onset.
5. If an mRNA vaccine is contraindicated, consideration can be given to boosting with an authorised non-mRNA vaccine following an individual benefit-risk assessment.
- Recommendation
- Europe
- Ireland
- COVID-19
